SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-016796
Filing Date
2023-05-15
Accepted
2023-05-12 21:17:43
Documents
83
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1946614
2 ex31-1.htm EX-31.1 18958
3 ex31-2.htm EX-31.2 18962
4 ex32-1.htm EX-32.1 9219
  Complete submission text file 0001493152-23-016796.txt   10901817

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ocx-20230331.xsd EX-101.SCH 76352
6 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ocx-20230331_cal.xml EX-101.CAL 77758
7 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ocx-20230331_def.xml EX-101.DEF 395750
8 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ocx-20230331_lab.xml EX-101.LAB 601066
9 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ocx-20230331_pre.xml EX-101.PRE 507241
77 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 2180276
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37648 | Film No.: 23917983
SIC: 2835 In Vitro & In Vivo Diagnostic Substances